Company Search:
Advanced Search
Sponsored Links
Latvijas Juras medicinas centrs AS Company Snapshot
Latvijas Juras medicinas centrs AS operates within the General medical & surgical hospitals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Latvijas Juras medicinas centrs AS with three other health care providers in Europe: Dom Lekarski SA of Poland (2016 sales of 34.61 million Polish New Zlotys [US$9.70 million] ), Celyad SA of Belgium (8.52 million Euro [US$10.03 million] of which 99% was Immuno-Oncology), and Institut Stvolovykh Kletok Cheloveka PAO which is based in Russia (390.36 million Russian Rubles [US$6.62 million] ).

Sales Analysis. During the year ended December of 2016, sales at Latvijas Juras medicinas centrs AS were 6.04 million Euro (US$7.11 million). This is an increase of 4.4% versus 2015, when the company's sales were 5.79 million Euro. This was the third consecutive year of growth at Latvijas Juras medicinas centrs AS.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Latvijas Juras medicinas centrs AS
  Stock Performance Chart for Latvijas Juras medicinas centrs AS
  Stock Data: Recent Stock Performance:
  Current Price (12/5/2017): 8.00
(Figures in Euro)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks 220.0%  
Latvijas Juras medicinas centrs AS Key Data:
  Ticker: LJM1R Country: Latvia
  Exchanges: Major Industry: Health Care Equipment & Services
    Sub Industry: General Medical & Surgical Hospitals
  2016 Sales 6,041,906
(Year Ending Jan 2017).
Employees: N/A
  Currency: Euro Market Cap: 6,400,000
  Fiscal Yr Ends: December Shares Outstanding: 800,000
  Share Type: Closely Held Shares: 590,640
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.